
AdvaMed CEO Scott Whitaker said the medtech lobbying group looks forward to working on policies that will unleash “the full potential of AI to help make America healthy again.”
AdvaMed CEO Scott Whitaker said the medtech lobbying group looks forward to working on policies that will unleash “the full potential of AI to help make America healthy again.”